
- /
- Supported exchanges
- / SA
- / FLRY3.SA
Fleury S.A. (FLRY3 SA) stock market data APIs
Fleury S.A. Financial Data Overview
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Fleury S.A. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Fleury S.A. data using free add-ons & libraries
Get Fleury S.A. Fundamental Data
Fleury S.A. Fundamental data includes:
- Net Revenue: 7 842 M
- EBITDA: 1 737 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: 0.29
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fleury S.A. News

Shares of Brazil's Fleury jump on reports of talks with Rede D'Or
SAO PAULO (Reuters) -Shares of Brazilian medical diagnostics company Fleury jumped on Monday after reports of a potential acquisition by hospital chain Rede D'Or, which analysts said could generate sy...


Fleury SA (BSP:FLRY3) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Gross Revenue: BRL2 billion in Q4 2024, an increase of 8.7% compared to Q4 2023. Annual Gross Revenue: BRL8.3 billion for 2024, a growth of 19.5% over 2023. EBITDA: BRL405.75 million in Q4 2024, up 7....

Fleury SA (BSP:FLRY3) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ...
Gross Revenue: BRL 2.1 billion, an increase of 6.1% compared to Q3 2023. EBITDA: BRL 347 million, a growth of 6.2% with a margin of 27.4%. Net Income: BRL 190.7 million, an increase of 9.5% with a net...

Miami F1 race a big boon for the sport — and for big brands
It was a thrilling end to the inaugural Miami F1 Grand Prix, in which Red Bull F1 driver Max Verstappen took the win despite a Ferrari (RACE) lockout of the first row of the grid after qualifying. Aft...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.